Calithera Biosciences
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch CALA and buy or sell other stocks, ETFs, and their options commission-free!About CALA
Calithera Biosciences, Inc. is a clinical-stage biopharmaceutical company, which focuses on discovering and developing small molecule drugs that target novel and critical metabolic pathways in tumor and cancer-fighting immune cells. It offers programs such as Pipeline, Glutaminase Inhibitor, and Arginase Inhibitor.
CEOSusan M. Molineaux
CEOSusan M. Molineaux
Employees63
Employees63
HeadquartersSouth San Francisco, California
HeadquartersSouth San Francisco, California
Founded2010
Founded2010
Employees63
Employees63
CALA Key Statistics
Market cap255.44M
Market cap255.44M
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume2.68M
Average volume2.68M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$2.49
52 Week high$2.49
52 Week low$0.139
52 Week low$0.139
Stock Snapshot
As of today, Calithera Biosciences(CALA) shares are valued at $2.61. The company's market cap stands at 255.44M.
During the trading day, Calithera Biosciences(CALA) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading volume for Calithera Biosciences(CALA) stock has reached 0, versus its average volume of 2.68M.
Over the past 52 weeks, Calithera Biosciences(CALA) stock has traded between a high of $2.49 and a low of $0.14.
Over the past 52 weeks, Calithera Biosciences(CALA) stock has traded between a high of $2.49 and a low of $0.14.
People also own
Based on the portfolios of people who own CALA. This list is generated using Robinhood data, and it’s not a recommendation.